Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Psychological Support Interventions for Women With Endometriosis (ENDOPSY)

NCT07280052 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-02
Last updated
2026-01-29

Condition(s) studied

Endometriosis

Investigational drug(s) / intervention(s)

Individual PsychotherapySocio-Aesthetic Group TherapyMixed Psychotherapy

Individual Psychotherapy: Ten individual psychotherapy sessions (45 minutes each) delivered every two weeks for 5 months by trained psychologists.

Socio-Aesthetic Group Therapy: Six socio-aesthetic therapy workshops (2 hours each) every two weeks over 3 months, focusing on body image, sensory experience, and emotional expression.

Mixed Psychotherapy: Combined individual and group psychotherapy including alternating sessions and final integrative sessions matching the number and duration of individual and group interventions.

Study summary

Endometriosis is associated with severe pain, impaired quality of life and significant psychological distress. Psychological support may help improve emotional regulation, mental health, and quality of life in affected women. This randomized controlled trial evaluates the impact of three psychological support interventions-individual psychotherapy, socio-aesthetic group therapy, and a mixed approach combining both-on psychological symptoms and quality of life. Forty participants will be randomized into four parallel arms. The study hypothesis is that psychological support interventions improve psychological functioning and disease-related quality of life compared with no intervention, and that the combined mixed approach may produce greater benefits than the individual or group interventions alone.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult women ≥18 years * Clinical diagnosis of endometriosis * Ability to understand and complete psychological evaluations * Signed written informed consent Exclusion Criteria: * Ongoing psychotherapy * Cognitive, sensory or language impairments preventing participation * Participation in another interventional clinical study * Persons under legal protection * Non-French speakers * Pregnancy or breastfeeding

Primary outcome measure(s)

  • Change in Endometriosis-Related Quality of Life (EHP-30 score) — Baseline (T1) and 5 months (T2)
    Change in the EHP-30 total score between baseline and post-intervention. Higher scores indicate worse quality of life.

Trial sites (1)

FacilityCityRegionStatus
Hôpital Lyon Sud - Hospices Civils de Lyon Pierre-Bénite France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07280052 on ClinicalTrials.gov ↗ ← All trials in France